中文 | English
Return
Total: 40 , 1/4
Show Home Prev Next End page: GO
Author:(Ke Feng DOU)

3.Development of SMART Technology and It’s Application

Wei-Hui LIU ; Ke-Feng DOU ;

China Biotechnology 2006;0(06):-

4.Comparison of the Efficacy for Diabetic Mice Xenotransplanted with Two Types of Microencapsulated Rat Islets

Qi XU ; Ke-feng DOU ; Zhen-shun SONG ; Fuqin ZHANG

Chinese Journal of Rehabilitation Theory and Practice 2006;12(5):383-384

6.Application of two bacteria colony-PCR methods in the screening of phage antibody library

Guo-Zhu XUE ; Ke-Feng DOU ; Yong-Gang LV ; Li-Bo YAO ;

Journal of Medical Postgraduates 2003;0(12):-

7.Protective effects of tumor necrosis factor-α antibody on pancreatic encephalopathy in rats

Yan-ling YANG ; Xiao-ping XU ; Ke-feng DOU ; Kaizong LI

Chinese Journal of Rehabilitation Theory and Practice 2004;10(3):165-166

8.Effect of hemodialysis with plasma-based dialysate plus high volume hemofiltration on plasma cytokines in patients with liver failure

Wei CHEN ; Hong-Bao LIU ; Zhen-Jiang LI ; Ke-Feng DOU ; Zhen-Shun SONG ; Yue-Qing XU ; Han-Min WANG ;

Chinese Journal of Nephrology 2005;0(12):-

9.Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells.

Bao-ding LI ; Qing-chuan ZHAO ; Yang-ting ZHU ; Fu-qin ZHANG ; Ke-feng DOU

Chinese Journal of Surgery 2006;44(7):458-462

10.Antitumor immune responses induced by gene transfer of 4-1BBL into hepatocellular carcinoma Hepa1-6 in vitro.

Cheng-li LIU ; Ke-feng DOU ; Xiao-xia ZANG ; Bang-fu ZHU ; Su-min CHEN

Chinese Journal of Surgery 2004;42(9):554-558

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 40 , 1/4 Show Home Prev Next End page: GO